Globe Life (NYSE:GL) Sets New 52-Week High – Should You Buy?

Globe Life Inc. (NYSE:GL)’s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $175.63 and last traded at $172.0670, with a volume of 895306 shares. The stock had previously closed at $170.76.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Wells Fargo & Company upped their price target on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a report on Friday, April 10th. Morgan Stanley lifted their price objective on Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, May 21st. TD Cowen boosted their price objective on Globe Life from $199.00 to $215.00 and gave the company a “buy” rating in a report on Tuesday. Weiss Ratings upgraded Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Finally, Truist Financial raised their target price on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $175.89.

Globe Life Price Performance

The stock has a market capitalization of $13.66 billion, a PE ratio of 12.17 and a beta of 0.49. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The stock’s fifty day moving average is $157.15 and its 200-day moving average is $146.77.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The firm had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the previous year, the firm posted $3.07 EPS. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities analysts predict that Globe Life Inc. will post 15.64 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s dividend payout ratio is presently 9.13%.

Insiders Place Their Bets

In other news, CEO James Matthew Darden sold 4,663 shares of the business’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the sale, the chief executive officer directly owned 58,451 shares in the company, valued at $8,994,439.88. The trade was a 7.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael Clay Majors sold 34,000 shares of the company’s stock in a transaction that occurred on Friday, April 24th. The stock was sold at an average price of $153.81, for a total value of $5,229,540.00. Following the transaction, the executive vice president directly owned 53,518 shares of the company’s stock, valued at approximately $8,231,603.58. The trade was a 38.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 115,929 shares of company stock worth $18,049,250. 2.11% of the stock is owned by company insiders.

Institutional Investors Weigh In On Globe Life

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. CYBER HORNET ETFs LLC purchased a new position in Globe Life during the second quarter valued at $28,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Globe Life in the fourth quarter valued at about $30,000. MUFG Securities EMEA plc purchased a new stake in shares of Globe Life during the second quarter worth about $31,000. Torren Management LLC purchased a new stake in shares of Globe Life during the fourth quarter worth about $37,000. Finally, AdvisorNet Financial Inc raised its position in shares of Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after purchasing an additional 92 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.